Should Degenerated Intervertebral Discs of Patients with Modic Type 1 Changes Be Treated with Mesenchymal Stem Cells?

Low back pain (LBP) has been among the leading causes of disability for the past 30 years. This highlights the need for improvement in LBP management. Many clinical trials focus on developing treatments against degenerative disc disease (DDD). The multifactorial etiology of DDD and associated risk f...

Descripción completa

Detalles Bibliográficos
Autores principales: Herger, Nick, Bermudez-Lekerika, Paola, Farshad, Mazda, Albers, Christoph E., Distler, Oliver, Gantenbein, Benjamin, Dudli, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910866/
https://www.ncbi.nlm.nih.gov/pubmed/35269863
http://dx.doi.org/10.3390/ijms23052721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910866/
https://www.ncbi.nlm.nih.gov/pubmed/35269863
http://dx.doi.org/10.3390/ijms23052721

Ejemplares similares